nifedipine has been researched along with darodipine in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (71.01) | 18.7374 |
1990's | 20 (28.99) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Ree, MM; Gahwiler, BH; Knot, HJ; Ruegg, UT | 1 |
Colombo, G; Fadda, F; Garau, B; Gessa, GL | 1 |
Hall, PF; Kawamura, M; Yanagibashi, K | 1 |
Atkinson, J; Devissaguet, JP; Guerret, M; Hoffman, M; Hubert, B; Maincent, P | 1 |
Doyle, VM; Hof, RP; Rüegg, UT; Zuber, JF | 1 |
Hof, A; Hof, RP; Kalkman, HO | 1 |
Creba, JA; Karobath, M | 1 |
Holck, M; Osterrieder, W | 1 |
Brown, DA; Gähwiler, BH | 1 |
Archer, DP; Pappius, HM | 1 |
Berg, C; DiFrancesco, GF; Gittos, M; Mir, AK; Petty, MA; Spedding, M | 1 |
Gerthoffer, WT; Shafer, PG; Taylor, S | 1 |
Bagwell, EE; Hungerford, RT; Lindenmayer, GE; Serafino, R | 1 |
Chaumet-Riffaud, P; Lemaire, M; Pinquier, JL; Tillement, JP; Urien, S | 1 |
Chaumet-Riffaud, P; Pinquier, JL; Tillement, JP; Urien, S | 1 |
Cooper, SM; Wilson, C | 1 |
Hof, RP | 5 |
Barnett, HJ; Bogousslavsky, J; Carruthers, SG; Hachinski, VC; Oczkowski, WJ | 1 |
Andersen, A; Paulson, OB; Vorstrup, S | 1 |
Krikler, DM | 1 |
Al-Mahmood, HA; el-Khatim, MS; Gumaa, KA; Thulesius, O | 1 |
Handley, DA; Melden, MK; Saunders, RN; Van Valen, RG | 1 |
Chaumet-Riffaud, P; Kiechel, JR; Paquette, B; Pinquier, JL; Tillement, JP; Urien, S | 1 |
Barrès, C; Cerutti, C; Morin, B; Sassard, J | 1 |
Jie, K; Timmermans, PB; van Brummelen, P; van Zwieten, PA; Vermey, P | 1 |
Chrysant, C; Chrysant, SG; Hitchcock, A; Trus, J | 1 |
de Buitleir, M; Krikler, DM; Krikler, S | 2 |
Raeburn, D; Roberts, JA; Rodger, IW; Thomson, NC | 1 |
Andersen, A; Blegvad, N; Paulson, OB; Vorstrup, S | 1 |
Ben-Dov, I; Hansen, JE; Olive, SR; Sue, DY; Wasserman, K | 1 |
Hof, A; Hof, RP | 1 |
Grebb, JA | 1 |
Carey, B; Ginsburg, R; Zera, P | 1 |
Ben-Dov, I; Hansen, JE; Sue, DY; Wasserman, K | 1 |
Bowles, MJ; Khurmi, NS; O'Hara, MJ; Raftery, EB | 1 |
Karobath, M; Supavilai, P | 1 |
Hess, T; Riesen, W; Salzmann, R; Scholtysik, G | 1 |
de Jonge, A; Kalkman, HO; Mathy, MJ; Thoolen, MJ; Timmermans, PB; van Meel, JC; van Zwieten, PA; Wilffert, B | 1 |
Dollery, CT; Ennis, M; Ind, PW; Pearce, FL | 1 |
Hof, A; Hof, RP; Loutzenhiser, R; Rüegg, UT | 1 |
Cortés, R; Karobath, M; Palacios, JM; Supavilai, P | 1 |
De Zoeten, K; Timmermans, PB; Van Meel, JC; Van Zwieten, PA; Wilffert, B | 1 |
Delgado, C; Diez, J; Tamargo, J; Tejerina, MT | 1 |
Nievelstein, HM; Smits, JF; Struyker-Boudier, HA; van Essen, H | 1 |
Advenier, C; Cerrina, J; Duroux, P; Floch, A; Renier, A | 1 |
Wiernsperger, N | 1 |
Hof, RP; Vuorela, HJ | 1 |
Brown, BL; Mac Neil, S; Tomlinson, S; Walker, SW | 1 |
Dall'Olio, R; Gaggi, R; Gianni, AM; Roncada, P | 1 |
Amenta, F; Ferrante, F; Mancini, M; Sabbatini, M; Vega, JA; Zaccheo, D | 1 |
Amenta, F; Cavallotti, D; Del Valle, M; Mancini, M; Naves, FJ; Vega, JA; Zeng, YC | 1 |
Amenta, F; Mancini, M; Naves, FJ; Vega, JA; Zaccheo, D | 1 |
Agabio, R; Colombo, G; Fadda, F; Gessa, GL; Lobina, C; Melis, F; Reali, R | 1 |
Amenta, F; Del Valle, ME; Sabbatini, M; Vega, JA | 1 |
Brée, F; Carrupt, PA; Giroud, Y; Testa, B; Tillement, JP; Tsai, RS; Urien, S | 1 |
Amenta, F; Ferrante, F; Ricci, A; Rossodivita, I | 1 |
Busico, S; Di Bon, G; Ferrari, A; Riela, S; Sannita, WG | 1 |
Rüegg, UT; Skutella, M | 1 |
Brauns, T; Glossmann, H; Haugland, RP; Kimball, SD; Prinz, H; Striessnig, J | 1 |
Dailly, E; Jolliet, P; Simon, N; Tillement, JP; Urien, S | 1 |
D'Allolio, R; Gaggi, R; Roncada, P; Santangelo, M | 1 |
Gauguier, D; Lathrop, GM; Samani, NJ; Sassard, J; Thompson, JR; Vincent, M | 1 |
Barbieri, M; Cerbai, E; Matucci, R; Mugelli, A; Ottaviani, MF | 1 |
Garbarino, S; Gesino, D; Massimilla, S; Ogliastro, C; Sannita, WG | 1 |
2 review(s) available for nifedipine and darodipine
Article | Year |
---|---|
PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular System; Cats; Chemoreceptor Cells; Coronary Circulation; Dogs; Drug Interactions; Electrophysiology; Guinea Pigs; Humans; In Vitro Techniques; Ion Channels; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Rabbits; Rats; Regional Blood Flow; Sinoatrial Node | 1985 |
Calcium antagonists for chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Myocardial Contraction; Nifedipine | 1987 |
10 trial(s) available for nifedipine and darodipine
Article | Year |
---|---|
A double-blind, randomized trial of PY108-068 in acute ischemic cerebral infarction.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Pilot Projects; Random Allocation; Severity of Illness Index | 1989 |
Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.
Topics: Adult; Azepines; Calcium Channel Blockers; Female; Forearm; Hemodynamics; Humans; Hypertension; Isradipine; Male; Methoxamine; Middle Aged; Nifedipine; Oxadiazoles; Receptors, Adrenergic, alpha; Regional Blood Flow; Vascular Resistance; Vasoconstriction | 1987 |
Monotherapy of hypertension with darodipine: a new calcium-channel blocker.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation | 1988 |
Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Nifedipine; Nitroglycerin; Random Allocation; Tablets | 1986 |
Comparison of PY 108-068, a new calcium antagonist, with nifedipine in exercise-induced asthma.
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Bronchi; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Pulmonary Ventilation; Random Allocation; Spirometry; Time Factors | 1986 |
PY 108-068--acute effects of a single oral dose in chronic stable angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Coronary Disease; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Nifedipine | 1986 |
Bronchodilatation and attenuation of exercise-induced bronchospasm by PY 108-068, a new calcium antagonist.
Topics: Adult; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Calcium Channel Blockers; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nifedipine; Pulmonary Ventilation; Time Factors; Vital Capacity | 1986 |
Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nifedipine | 1985 |
Pharmacokinetics and electroencephalographic effects of darodipine 50-200 mg modified release (MR) acute oral administration: dose-finding study in healthy volunteers.
Topics: Administration, Oral; Adult; Blood Pressure; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Follow-Up Studies; Heart Rate; Humans; Male; Nifedipine | 1993 |
Plasma concentration and CNS effects of Ca antagonists darodipine and nimodipine after single-dose oral administration to healthy volunteers.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Central Nervous System; Electroencephalography; Heart Rate; Humans; Male; Neuropsychological Tests; Nifedipine; Nimodipine | 1999 |
57 other study(ies) available for nifedipine and darodipine
Article | Year |
---|---|
Action of vasoconstrictor hormones and calcium entry modulators on electrical activity and intracellular calcium of smooth muscle cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Barium; Barium Compounds; Cadmium; Cadmium Chloride; Calcium Channel Blockers; Cell Line; Chlorides; Membrane Potentials; Muscle, Smooth, Vascular; Nifedipine; Vasoconstrictor Agents; Vasopressins | 1992 |
Isradipine and other calcium channel antagonists attenuate ethanol consumption in ethanol-preferring rats.
Topics: Alcohol Drinking; Animals; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Ethanol; Isradipine; Male; Nifedipine; Rats; Rats, Inbred Strains; Verapamil | 1992 |
Voltage-dependent Ca2+ channels are involved in regulation of steroid synthesis by bovine but not rat fasciculata cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Bucladesine; Calcium; Calcium Channel Blockers; Calcium Channels; Cattle; Female; Nifedipine; Potassium; Rats; Rats, Inbred Strains; Zona Fasciculata; Zona Reticularis | 1990 |
The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Capsules; Hypertension, Renovascular; Male; Nifedipine; Rats; Rats, Inbred Strains; Suspensions | 1991 |
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels.
Topics: Animals; Biological Transport; Calcium; Calcium-Transporting ATPases; Cell Line; Ion Channels; Membrane Potentials; Muscle, Smooth, Vascular; Nifedipine; Potassium Chloride; Rats; Sodium-Potassium-Exchanging ATPase; Verapamil | 1985 |
Modification of the vasoconstrictor effects of noradrenaline and serotonin by the selective calcium antagonist PY 108-068 in the peripheral circulation of anesthetized cats.
Topics: Animals; Cats; Drug Administration Schedule; Hemodynamics; Nifedipine; Norepinephrine; Regional Blood Flow; Serotonin Antagonists; Vasoconstriction | 1985 |
The effect of dihydropyridine calcium agonists and antagonists on neuronal voltage sensitive calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aminoquinolines; Animals; Brain Chemistry; Calcium; Calcium Channel Blockers; Cell Line; Dihydropyridines; Electric Stimulation; Glioma; In Vitro Techniques; Ion Channels; Neuroblastoma; Neurons; Nifedipine; Potassium; Pyridines; Rats; Synaptosomes; Verapamil | 1986 |
Inhibition of myocardial Ca2+ channels by three dihydropyridines with different structural features: potential-dependent blockade by Ro 18-3981.
Topics: Animals; Calcium Channel Blockers; Dihydropyridines; Female; Guinea Pigs; Heart; In Vitro Techniques; Ion Channels; Isradipine; Male; Membrane Potentials; Myocardial Contraction; Myocardium; Nifedipine; Oxadiazoles; Potassium; Pyridines | 1987 |
Effects of dihydropyridines on calcium currents in CA3 pyramidal cells in slice cultures of rat hippocampus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Cadmium; Calcium; Electric Conductivity; Hippocampus; In Vitro Techniques; Membrane Potentials; Nifedipine; Rats | 1987 |
Effects of two dihydropyridine calcium channel blockers on cerebral metabolism and blood flow in traumatized rat brain.
Topics: Animals; Blood Glucose; Brain; Brain Injuries; Calcium; Calcium Channel Blockers; Cerebrovascular Circulation; Energy Metabolism; Freezing; Ion Channels; Male; Nifedipine; Nimodipine; Parietal Lobe; Rats; Rats, Inbred Strains | 1986 |
MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia.
Topics: Animals; Bradycardia; Calcium Channel Blockers; Calcium Channels; Decerebrate State; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Guinea Pigs; Hypertension, Renal; Male; Nicotinic Acids; Nifedipine; Nitrendipine; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Vasodilation | 1987 |
Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Basilar Artery; Calcium; Calcium Channel Blockers; Dinoprost; Dogs; Dose-Response Relationship, Drug; Nifedipine; Phenytoin; Potassium; Prostaglandins F; Serotonin; Vasoconstriction; Vasodilation | 1987 |
Relationship between steady-state depression of calcium-dependent action potentials and competition for binding sites by nifedipine, nitrendipine, and PY 108-068.
Topics: Action Potentials; Animals; Binding, Competitive; Calcium; Dogs; Heart; In Vitro Techniques; Myocardium; Nifedipine; Nitrendipine; Purkinje Fibers | 1987 |
Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
Topics: Binding, Competitive; Blood Proteins; Calcium Channel Blockers; Dihydropyridines; Erythrocytes; gamma-Globulins; Humans; Isradipine; Lipoproteins; Nifedipine; Pyridines | 1988 |
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
Topics: Adult; Blood Proteins; Calcium Channel Blockers; Fatty Acids, Nonesterified; Female; Humans; Hydrogen-Ion Concentration; Inflammation; Isradipine; Liver Diseases; Male; Middle Aged; Nifedipine; Orosomucoid; Protein Binding; Pyridines; Serum Albumin | 1989 |
Effect of cromakalim on contractions in rabbit isolated renal artery in the presence and absence of extracellular Ca2+.
Topics: Animals; Benzopyrans; Caffeine; Calcium; Calcium Channel Blockers; Cromakalim; Guanidines; Guanylate Cyclase; Histamine; In Vitro Techniques; Lanthanum; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitroprusside; Norepinephrine; Pinacidil; Pyrroles; Rabbits; Renal Artery; Vasodilator Agents | 1989 |
CBF decreases after calcium antagonist treatment in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Nifedipine | 1989 |
The effect of calcium-blockers nicardipine, darodipine, PN-200-110 and nifedipine on insulin release from isolated rat pancreatic islets.
Topics: Animals; Calcium Channel Blockers; Cells, Cultured; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isradipine; Male; Nicardipine; Nifedipine; Oxadiazoles; Rats; Rats, Inbred Strains | 1986 |
Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Blood Platelets; Blood Pressure; Carotid Arteries; Hypotension; Isradipine; Male; Muscle, Smooth, Vascular; Nifedipine; Oxadiazoles; Rats; Rats, Inbred Strains | 1986 |
Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the rat blood-brain barrier. Drug binding to lipoproteins does not limit the transfer of drug.
Topics: Animals; Biological Transport; Blood Proteins; Blood-Brain Barrier; Brain; Humans; Isradipine; Lipoproteins; Liver; Male; Nifedipine; Orosomucoid; Pyridines; Rats; Rats, Inbred Strains; Serum Albumin | 1987 |
Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Isradipine; Male; Nifedipine; Nitroglycerin; Oxadiazoles; Phenylephrine; Pressoreceptors; Rats; Rats, Inbred SHR; Reflex | 1988 |
Agonist-induced contractile responses of human bronchial muscle in vitro: effects of Ca2+ removal, La3+ and PY108068.
Topics: Bronchi; Calcimycin; Calcium; Calcium Channel Blockers; Histamine; Humans; In Vitro Techniques; Lanthanum; Methacholine Chloride; Methacholine Compounds; Muscle Contraction; Muscle, Smooth; Nifedipine; Potassium Chloride; SRS-A | 1986 |
Calcium antagonist (PY 108-068) treatment may further decrease flow in ischemic areas in acute stroke.
Topics: Acute Disease; Adult; Aged; Brain; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Nifedipine; Time Factors; Tomography, Emission-Computed; Vasodilation | 1986 |
Mutual inhibition and synergistic effects of ergotamine and the calcium antagonist darodipine.
Topics: Animals; Calcium Channel Blockers; Cats; Drug Synergism; Ergotamine; Hemodynamics; Nifedipine; Organ Specificity; Regional Blood Flow; Vasoconstriction | 1986 |
Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice.
Topics: Animals; Calcium Channel Blockers; Cinnarizine; Dextroamphetamine; Dose-Response Relationship, Drug; Flunarizine; Mice; Motor Activity; Nifedipine | 1986 |
Effect of calcium antagonist darodipine on the isolated human heart.
Topics: Calcium; Calcium Channel Blockers; Carbachol; Coronary Vessels; Heart; Histamine; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Nifedipine; Potassium Chloride | 1986 |
Vasopressin induced myocardial depression in neurally mediated and not due to impaired coronary blood flow.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Circulation; Hemodynamics; Lypressin; Microspheres; Nifedipine; Rabbits; Reflex | 1986 |
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits.
Topics: Anesthesia; Angiotensin II; Animals; Calcium Channel Blockers; Hemodynamics; Lypressin; Microspheres; Nifedipine; Rabbits; Regional Blood Flow; Vasoconstriction | 1985 |
The interaction of [3H]PY 108-068 and of [3H]PN 200-110 with calcium channel binding sites in rat brain.
Topics: Animals; Brain; In Vitro Techniques; Ion Channels; Isradipine; Kinetics; Male; Membranes; Molecular Conformation; Nifedipine; Oxadiazoles; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1984 |
Digoxin-specific antibody fragments and a calcium antagonist for reversal of digoxin-induced mesenteric vasoconstriction.
Topics: Anesthesia; Animals; Blood Pressure; Calcium Channel Blockers; Cats; Digoxin; Female; Heart Rate; Immunoglobulin Fab Fragments; In Vitro Techniques; Male; Nifedipine; Splanchnic Circulation; Vasoconstriction | 1983 |
Differential effect of calcium entry blockers on alpha 1-adrenoceptor-mediated vasoconstriction in vivo.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Calcium Channel Blockers; Catecholamines; Clonidine; Ethanolamines; Imidazoles; Imidazolines; Male; Methoxamine; Nifedipine; Phenylephrine; Rats; Rats, Inbred Strains; Vasoconstriction; Verapamil | 1983 |
Calcium antagonists and histamine secretion from rat peritoneal mast cells.
Topics: Animals; Ascitic Fluid; Calcium; Calcium Channel Blockers; Female; Histamine Release; In Vitro Techniques; Male; Mast Cells; Nifedipine; Rats; Rats, Inbred Strains; Verapamil | 1983 |
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nifedipine; Potassium Chloride; Pyridines; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 1984 |
Calcium antagonist binding sites in the rat brain: quantitative autoradiographic mapping using the 1,4-dihydropyridines [3H]PN 200-110 and [3H]PY 108-068.
Topics: Animals; Autoradiography; Binding Sites; Brain; Calcium Channel Blockers; Isradipine; Male; Nifedipine; Oxadiazoles; Rats; Rats, Inbred Strains | 1984 |
The inhibitory effect of newer calcium antagonists (nimodipine and PY-108-068) on vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors.
Topics: Animals; Azepines; Blood Pressure; Calcium Channel Blockers; Heart Rate; Male; Methoxamine; Nicotinic Acids; Nifedipine; Nimodipine; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Vasoconstriction | 1982 |
Inotropic and electrophysiological effects of PY 108-068 on isolated cardiac preparations.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Electric Stimulation; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Membrane Potentials; Myocardial Contraction; Nifedipine; Papillary Muscles; Rats; Verapamil | 1984 |
Calcium antagonists: systemic and regional haemodynamic effects in conscious spontaneously hypertensive rats (SHR).
Topics: Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemodynamics; Male; Nifedipine; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Reflex; Sinoatrial Node; Verapamil; Wakefulness | 1984 |
Effects of five different organic calcium antagonists on guinea-pig isolated trachea.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nicardipine; Nifedipine; Pyrrolidines; Trachea; Verapamil | 1984 |
Focal epicerebral ischemia: post-ischemic tissue oxygenation with and without recirculation.
Topics: Animals; Aspirin; Cats; Cerebrovascular Circulation; Injections, Intravenous; Ischemic Attack, Transient; Nifedipine; Oxygen Consumption | 1984 |
The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.
Topics: Anesthesia; Angiotensin II; Animals; Calcium Channel Blockers; Cardiac Output; Cats; Hemodynamics; Neural Conduction; Nifedipine; Regional Blood Flow; Vascular Resistance; Verapamil | 1984 |
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
Topics: Animals; Calcium Channel Blockers; Cats; Diltiazem; Hemodynamics; Microspheres; Neural Conduction; Nicardipine; Nifedipine; Regional Blood Flow; Verapamil | 1983 |
Assessing calcium antagonism on vascular smooth muscle: a comparison of three methods.
Topics: Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Female; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Potassium Chloride; Rabbits; Verapamil | 1983 |
Evidence that calmodulin may be involved in phytohaemagglutinin-stimulated lymphocyte division.
Topics: Calcium-Binding Proteins; Calmodulin; DNA Replication; Humans; Lymphocyte Activation; Lymphocytes; Nifedipine; Phytohemagglutinins; Pyridines; Sulfonamides; Trifluoperazine; Vasodilator Agents | 1982 |
Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium Channel Blockers; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Injections, Intraperitoneal; Isradipine; Male; Motor Activity; Nifedipine; Nimodipine; Parietal Lobe; Rats; Rats, Sprague-Dawley | 1995 |
Effect of long-term treatment with the dihydropyridine-type calcium channel blocker darodipine (PY 108-068) on the cerebral capillary network in aged rats.
Topics: Aging; Alkaline Phosphatase; Analysis of Variance; Animals; Calcium Channel Blockers; Capillaries; Cerebral Cortex; Cerebrovascular Circulation; Hippocampus; Male; Nifedipine; Random Allocation; Rats; Rats, Wistar | 1995 |
Age-related changes in brain microanatomy: sensitivity to treatment with the dihydropyridine calcium channel blocker darodipine (PY 108-068).
Topics: Aging; Alkaline Phosphatase; Animals; Brain; Calcium Channel Blockers; Lipofuscin; Male; Neurons; Nifedipine; Rats; Rats, Wistar; Tissue Distribution | 1995 |
Effect of treatment with the dihydropyridine-type calcium antagonist darodipine (PY 108-068) on the expression of calbindin D-28K immunoreactivity in the cerebellar cortex of aged rats.
Topics: Aging; Animals; Calbindins; Calcium Channel Blockers; Cerebellar Cortex; Immunohistochemistry; Male; Molecular Weight; Nerve Tissue Proteins; Nifedipine; Rats; Rats, Wistar; S100 Calcium Binding Protein G; Tissue Distribution | 1995 |
Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Ethanol; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Weight Loss | 1995 |
Effect of treatment with the dihydropyridine-type calcium antagonist darodipine (PY 108-068) on the expression of neurofilament protein immunoreactivity in the cerebellar cortex of aged rats.
Topics: Aging; Animals; Calcium Channel Blockers; Cerebellar Cortex; Immunohistochemistry; Male; Neurofilament Proteins; Nifedipine; Rats; Rats, Wistar | 1994 |
Mechanism of ligand binding to alpha 1-acid glycoprotein (orosomucoid): correlated thermodynamic factors and molecular parameters of polarity.
Topics: Binding Sites; Chemical Phenomena; Chemistry, Physical; Hydrogen Bonding; Indoles; Isradipine; Ligands; Nifedipine; Orosomucoid; Progesterone; Propanolamines; Propranolol; Temperature; Thermodynamics; Warfarin | 1995 |
Influence of treatment with the calcium channel blocker darodipine (PY 108-068) on the morphology of pial and coronary arteries in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cerebral Arteries; Coronary Vessels; Male; Nifedipine; Pia Mater; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent.
Topics: Animals; Arginine Vasopressin; Biological Transport; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Cell Compartmentation; Cell Membrane; Cells, Cultured; Chelating Agents; Cytoplasm; Egtazic Acid; Enzyme Inhibitors; Imidazoles; Kinetics; Muscle, Smooth, Vascular; Nifedipine; Rats; Terpenes; Thapsigargin | 1996 |
L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Fluorescent Dyes; Isomerism; Isradipine; Kinetics; Nicotinic Acids; Nifedipine; Nitrendipine; Oxadiazoles; Rabbits | 1997 |
pH dependent binding of ligands to serum lipoproteins.
Topics: Hydrogen-Ion Concentration; Indoles; Lipoproteins; Nicardipine; Nifedipine; Protein Binding; Spectrum Analysis | 1997 |
Interactions between darodipine or isradipine and the 5-HT1A receptor agonist 8-OHDPAT in rat brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Interactions; Isradipine; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1997 |
A pharmacogenetic approach to blood pressure in Lyon hypertensive rats. A chromosome 2 locus influences the response to a calcium antagonist.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Chromosome Mapping; Crosses, Genetic; Diastole; Disease Models, Animal; Female; Hypertension; Lod Score; Male; Microsatellite Repeats; Nifedipine; Phenotype; Quantitative Trait, Heritable; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Systole | 1997 |
Protective effect of darodipine, a calcium antagonist, on rat cardiomyocytes against oxygen radical-mediated injury.
Topics: Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Electrophysiology; Free Radicals; Heart; Male; Membrane Potentials; Myocardium; Nifedipine; Rats; Rats, Wistar; Reactive Oxygen Species | 1997 |